Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)
China flag China · Delayed Price · Currency is CNY
5.76
-0.10 (-1.71%)
Nov 18, 2026, 3:00 PM CST

SHA:600613 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,8031,9522,0482,3402,3882,300
Other Revenue
0.620.620.510.680.222.92
1,8041,9522,0492,3412,3892,303
Revenue Growth
-4.22%-4.71%-12.48%-2.00%3.72%26.61%
Cost of Revenue
1,0441,0891,0971,1891,125918.13
Gross Profit
760.37863.82951.711,1521,2631,385
Selling, General & Admin
632.61718.19784.631,0021,0971,232
Research & Development
28.0730.2432.8932.345.9950.95
Other Operating Expenses
24.6825.9324.5826.5129.6227.22
Operating Expenses
709.09794.18858.281,0251,1781,294
Operating Income
51.2869.6493.43126.3785.7990.69
Interest Expense
-7.87-10.07-12.8-14.76-17.37-8.34
Interest & Investment Income
9.2710.4310.855.978.1730.51
Currency Exchange Gain (Loss)
0.010.01-0.1200-0
Other Non Operating Income (Expenses)
0.75-1.94-3.6211.79-13.916.17
EBT Excluding Unusual Items
53.4568.0887.74129.3762.69119.03
Impairment of Goodwill
----55.21--
Gain (Loss) on Sale of Investments
-4.290.55-0.020.9--
Gain (Loss) on Sale of Assets
0.560.22-0.370.17-5.23-0
Asset Writedown
-1.6--1.47-0.47-2.72-26.72
Other Unusual Items
0.82.031.78.668.497.29
Pretax Income
48.9170.8787.5883.4163.2399.6
Income Tax Expense
33.2531.0421.525.1514.9331.64
Earnings From Continuing Operations
15.6639.8466.0858.2648.2967.96
Minority Interest in Earnings
-7-1.595.31-1.260.251.66
Net Income
8.6538.2471.395748.5569.62
Net Income to Common
8.6538.2471.395748.5569.62
Net Income Growth
-86.12%-46.43%25.24%17.41%-30.27%-
Shares Outstanding (Basic)
516546549518539536
Shares Outstanding (Diluted)
516546549518539536
Shares Change
-8.54%-0.51%5.97%-3.94%0.72%0.46%
EPS (Basic)
0.020.070.130.110.090.13
EPS (Diluted)
0.020.070.130.110.090.13
EPS Growth
-84.82%-46.15%18.18%22.22%-30.77%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
91.3891.26171.39191.08292.5998.3
Free Cash Flow Per Share
0.180.170.310.370.540.18
Dividend Per Share
0.0700.0700.1500.1000.1000.100
Dividend Growth
-53.33%-53.33%50.00%0%0%-
Gross Margin
42.15%44.25%46.45%49.20%52.90%60.13%
Operating Margin
2.84%3.57%4.56%5.40%3.59%3.94%
Profit Margin
0.48%1.96%3.48%2.44%2.03%3.02%
Free Cash Flow Margin
5.07%4.67%8.37%8.16%12.25%4.27%
EBITDA
122.55143.97171.83207.57170.59147.2
EBITDA Margin
6.79%7.37%8.39%8.87%7.14%6.39%
D&A For EBITDA
71.2774.3378.4181.284.856.51
EBIT
51.2869.6493.43126.3785.7990.69
EBIT Margin
2.84%3.57%4.56%5.40%3.59%3.94%
Effective Tax Rate
67.99%43.79%24.55%30.15%23.62%31.76%
Revenue as Reported
1,8041,9522,0492,3412,3892,303